ANTI-MAG NEUROPATHY
Clinical trials for ANTI-MAG NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new ANTI-MAG NEUROPATHY trials appear
Sign up with your email to follow new studies for ANTI-MAG NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug ease this rare nerve disorder?
Disease control Recruiting nowThis phase 3 trial tests whether rituximab, a drug used for certain blood cancers, can improve daily function in people with anti-MAG neuropathy—a rare, progressive nerve condition. About 90 adults with early-stage disease and specific antibody levels will receive the drug. The m…
Matched conditions: ANTI-MAG NEUROPATHY
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New nerve test could spot rare disease types faster
Knowledge-focused Recruiting nowThis study looks at how nerves send signals in people with Charcot-Marie-Tooth disease and other nerve disorders like CIDP. Researchers will use special electrical tests and ultrasound to measure nerve function and size. The goal is to find better ways to tell these conditions ap…
Matched conditions: ANTI-MAG NEUROPATHY
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC